Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy (MACAARET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02444832
Recruitment Status : Unknown
Verified May 2015 by Federico Zarco, Hospital Clinic of Barcelona.
Recruitment status was:  Recruiting
First Posted : May 15, 2015
Last Update Posted : May 15, 2015
Sponsor:
Collaborators:
Hospitales Universitarios Virgen del Rocío
Hospital Universitario Reina Sofia de Cordoba
Information provided by (Responsible Party):
Federico Zarco, Hospital Clinic of Barcelona

Brief Summary:

Based on the anatomical features of the anterior Communicating artery complex, the investigators will analyze the outcome of the ACoA aneurysms treated by endovascular therapy.

The most common site of intracranial aneurysms is the anterior communicating artery (AcomA). AcomA aneurysms account for approximately one-fourth of all intracranial aneurysms.

Recent publications have addressed specifically the endovascular treatment of AcoA aneurysms. Furthermore, detailed anatomic characteristics and the effects of the multiple variations of the anterior communicating artery complex have scarcely been reported.

The hemodynamic factors play a fundamental role in the adequate treatment of aneurismal coiling.

The objective of our registry is to analyze the impact of morphological configuration of the anterior communicating artery complex and the results of coil embolization in AcoA aneurysms


Condition or disease
Intracranial Aneurysm Anterior Communicating Artery Aneurysm Cerebral Aneurysm Aneurysm, Ruptured

Layout table for study information
Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Multicenter Retrospective Registry of Anterior Communicating Artery Aneurysms With Endovascular Therapy
Study Start Date : May 2015
Estimated Primary Completion Date : June 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Aneurysms




Primary Outcome Measures :
  1. Effective Aneurysm Coiling (no residual cerebral aneurysm) [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. All Cause Mortality [ Time Frame: 1 year ]
  2. Neurological Outcome (classified with the Glasgow Outcome Scale, Rankin Scale) [ Time Frame: 1 year ]
    All patients will be classified with the Glasgow Outcome Scale, Rankin Scale.

  3. Procedural device-related serious adverse events [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with Communicating Artery Aneurysm treated with endovascular coiling.
Criteria

Inclusion Criteria:

  • Patient with Anterior Communicating Artery Aneurysm treated with endovascular coiling.

Exclusion Criteria:

  • Patients without imaging follow up of at least 12 months after endovascular treatment.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02444832


Contacts
Layout table for location contacts
Contact: Federico Zarco, MD 932275400 ext 2662 fzarco@clinic.ub.es

Locations
Layout table for location information
Spain
Hospital Clinic Recruiting
Barcelona, Spain, 08036
Contact: Federico Zarco, MD    932 27 54 00 ext 2662    fzarco@clinic.ub.es   
Contact: Federico         
Principal Investigator: Federico Zarco, MD         
Principal Investigator: Antonio Lopez Rueda, MD         
Sub-Investigator: Juan Macho Fernandez, MD         
Sub-Investigator: Fernando Delgado, MD         
Sub-Investigator: Alejandro González García, MD         
Sub-Investigator: Mariano Werner, MD         
Sub-Investigator: Oscar Chirife, MD         
Sub-Investigator: Napoleón Macias, MD         
Sub-Investigator: Luis San Roman, MD         
Sub-Investigator: Jordi Blasco, MD         
Sponsors and Collaborators
Hospital Clinic of Barcelona
Hospitales Universitarios Virgen del Rocío
Hospital Universitario Reina Sofia de Cordoba
Investigators
Layout table for investigator information
Principal Investigator: Federico Zarco, MD Hospital Clinic of Barcelona
Publications:
Layout table for additonal information
Responsible Party: Federico Zarco, Neurorradiologist,, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier: NCT02444832    
Other Study ID Numbers: NeurovascCDI001
First Posted: May 15, 2015    Key Record Dates
Last Update Posted: May 15, 2015
Last Verified: May 2015
Additional relevant MeSH terms:
Layout table for MeSH terms
Intracranial Aneurysm
Aneurysm
Aneurysm, Ruptured
Vascular Diseases
Cardiovascular Diseases
Intracranial Arterial Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases